Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic Prediction of Metoprolol Effectiveness
NCT02293096Terminated
- Sponsor
- University of Colorado Denver
- Start
- Sep 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metoprolol in hypertension (HTN), sponsored by University of Colorado Denver. Primary endpoint: Blood Pressure Decline. Started Sep 2014; status: terminated.
02
Drugs
metoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02293096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293096.